diabetic%20retinopathy
DIABETIC RETINOPATHY
Diabetic retinopathy is an abnormality of the microvasculature of the retina that occurs to almost all patients with chronic diabetes mellitus.
It is one of the leading cause of blindness worldwide and principal cause of impaired vision in patients aged 25-75 years of age.
The abnormality causes microaneurysms, retinal hemorrhages, lipid exudates, macular edema & neovascular vessel growth that may lead to blindness.

Diabetic%20retinopathy Signs and Symptoms

Introduction

  • Diabetic Retinopathy (DR) is a progressive retinal disorder that occurs to almost all patients w/ chronic diabetes mellitus (DM)
  • One of the leading causes of blindness worldwide
  • Principal cause of impaired vision in patients aged 25-75 yrs old
  • Leading complication of DM
  • Earliest visible manifestations are microaneurysms & hemorrhages

Pathophysiology

  • Believed to be a result of different biochemical changes (eg aldose reductase, protein glycation, protein kinase C activation, angiotensin enzyme expression, vascular endothelial growth factor expression, etc) accompanied by blood retinal barrier increased permeability & initially by increases in retinal blood flow
    • Resulting widened venular caliber is a marker of the severity of DR

Signs and Symptoms

Clinical Presentation

  • Initial clinical signs of DR are:
    • Thickening of the retinal basement membrane
    • Microaneurysms or hypercellular outpouchings of retinal capillaries w/ weakened walls due to pericyte loss
    • Leakage of lipid & proteinaceous material (hard exudates)
  • Signs that would lead to visual impairment:
    • Presence of macular edema
    • Presence of new vessels at the optic disc (NVD) or new vessels elsewhere in the retina (NVE)
    • Manifestations of severe NPDR that includes: extensive retinal hemorrhages/microaneurysms, venous beading & intraretinal microvascular abnormalities (IRMA)
    • Vitreous or preretinal hemorrhage
  • The basic changes in the retinal vessels are:
    • Abnormal permeability & vascular occlusion w/ ischemia
    • Subsequent neovascularization
  • Typical retinal microvascular lesions of DR are:
    • Microaneurysms
    • Hard exudates
    • IRMA
    • New vessels or neovascularization
    • Hemorrhages
    • Cotton wool spots
    • Venous beading
    • Fibrous tissue

Risk Factors

  • Visual loss from DR is caused either by:
    • Macular edema
    • Vitreous hemorrhage
    • Neovascular glaucoma
    • Macular capillary nonperfusion
    • Distortion or traction detachment of the retina
  • The major risk factors in the development of DR are the duration of diabetes & the severity of hyperglycemia; other risk factors include pregnancy, puberty, cataract surgery, medical conditions (eg hypertension, hyperlipidemia)
Editor's Recommendations
Most Read Articles
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Pearl Toh, 6 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Elvira Manzano, 17 Nov 2020
Invasive fungal infections, particularly those caused by Candida species, are common in hospitalized, immunocompromised, or critically ill patients and are associated with considerable morbidity and mortality.